Following the publication of the original article [1], we were notified that the name of the 9th author was incorrectly spelled as Massimo FilippiBonassi, instead of Massimo Filippi. The original article has been corrected.

Correction to: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study) (The Journal of Headache and Pain, (2022), 23, 1, (46), 10.1186/s10194-022-01396-x)

Cetta I.;Filippi M.;
2022-01-01

Abstract

Following the publication of the original article [1], we were notified that the name of the 9th author was incorrectly spelled as Massimo FilippiBonassi, instead of Massimo Filippi. The original article has been corrected.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/138280
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 1
social impact